{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:45:46Z","timestamp":1781617546964,"version":"3.54.5"},"reference-count":35,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PB-PG-0817-20023"],"award-info":[{"award-number":["PB-PG-0817-20023"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,3]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Liver transplantation is a complex operation that can provide significant improvements in quality of life and survival to the recipients. However, serious complications are common and include major haemorrhage, hypotension and renal failure. Blood transfusion and the development of acute kidney injury lead to both short-term and long-term poor patient outcomes, including an increased risk of death, graft failure, length of stay and reduced quality of life. Octreotide may reduce the incidence of renal dysfunction, perioperative haemorrhage and enhance intraoperative blood pressure. However, octreotide does have risks, including resistant bradycardia, hyperglycaemia and hypoglycaemia and QT prolongation. Hence, a randomised controlled trial of octreotide during liver transplantation is needed to determine the cost-efficacy and safety of its use; this study represents a feasibility study prior to this trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We describe a multicentre, double-blind, randomised, placebo-controlled feasibility study of continuous infusion of octreotide during liver transplantation surgery. We will recruit 30 adult patients at two liver transplant centres. A blinded infusion during surgery will be administered in a 2:1 ratio of octreotide:placebo. The primary outcomes will determine the feasibility of this study design. These include the recruitment ratio, correct administration of blinded study intervention, adverse event rates, patient and clinician enrolment refusal and completion of data collection. Secondary outcome measures of efficacy and safety will help shape future trials by assessing potential primary outcome measures and monitoring safety end points. No formal statistical tests are planned. This manuscript represents study protocol number 1.3, dated 2 June 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has received Research Ethics Committee approval. The main study outcomes will be submitted to an open-access journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial sponsor<\/jats:title>\n                    <jats:p>The Joint Research Office, University College London, UK.<\/jats:p>\n                    <jats:p>Neither the sponsor nor the funder have any role in study design, collection, management, analysis and interpretation of data, writing of the study report or the decision to submit the report for publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The study is registered with ClinicalTrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04941911\">NCT04941911<\/jats:ext-link>\n                      ) with recruitment due to start in August 2021 with anticipated completion in July 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trials unit<\/jats:title>\n                    <jats:p>Surgical and Interventional Group, Division of Surgery &amp; Interventional Science, University College London.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-055864","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T11:59:06Z","timestamp":1638446346000},"page":"e055864","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04941911","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04941911","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-5973","authenticated-orcid":false,"given":"Jeremy","family":"Fabes","sequence":"first","affiliation":[{"name":"Peninsula Medical School, University of Plymouth, Plymouth, Devon, UK"},{"name":"Department of Anaesthesia, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Ambler","sequence":"additional","affiliation":[{"name":"Department of Statistical Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bina","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Surgery & Interventional Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman R","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Surgery & Interventional Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martin","sequence":"additional","affiliation":[{"name":"Peninsula Medical School, University of Plymouth, Plymouth, Devon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Division of Surgery & Interventional Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spiro","sequence":"additional","affiliation":[{"name":"Division of Surgery & Interventional Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2025121400210048000_11.12.e055864.1","unstructured":"NHSBT . Annual report on liver transplantation (2019-2020); 2020 [Accessed 20 Apr 2021]."},{"key":"2025121400210048000_11.12.e055864.2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jamcollsurg.2012.12.047","article-title":"Blood transfusion requirement during liver transplantation is an important risk factor for mortality","volume":"216","author":"Rana","year":"2013","journal-title":"J Am Coll Surg"},{"key":"2025121400210048000_11.12.e055864.3","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000289638.26666.ed"},{"key":"2025121400210048000_11.12.e055864.4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00423-014-1181-y","article-title":"Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival","volume":"399","author":"Reichert","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"2025121400210048000_11.12.e055864.5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007133"},{"key":"2025121400210048000_11.12.e055864.6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00432-017-2376-8","article-title":"Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation","volume":"143","author":"Chen","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"2025121400210048000_11.12.e055864.7","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v9.i18.823","article-title":"Early acute kidney injury after liver transplantation: predisposing factors and clinical implications","volume":"9","author":"Rahman","year":"2017","journal-title":"World J Hepatol"},{"key":"2025121400210048000_11.12.e055864.8","first-page":"258","article-title":"Incidence and patient outcomes in renal replacement therapy after orthotopic liver transplant","volume":"15","author":"Ayhan","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"2025121400210048000_11.12.e055864.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.08.059"},{"key":"2025121400210048000_11.12.e055864.10","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120022546"},{"key":"2025121400210048000_11.12.e055864.11","first-page":"S7","article-title":"Acute renal failure and chronic kidney disease following liver transplantation","author":"Yalavarthy","year":"2007"},{"key":"2025121400210048000_11.12.e055864.12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/oxfordjournals.ndt.a091713","article-title":"Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis","volume":"3","author":"Mountokalakis","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"2025121400210048000_11.12.e055864.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80025-7"},{"key":"2025121400210048000_11.12.e055864.14","doi-asserted-by":"crossref","DOI":"10.1038\/srep42701","article-title":"Octreotide attenuates acute kidney injury after hepatic ischemia and reperfusion by enhancing autophagy","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"key":"2025121400210048000_11.12.e055864.15","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.12787","article-title":"The effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Sahmeddini","year":"2013","journal-title":"Hepat Mon"},{"key":"2025121400210048000_11.12.e055864.16","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.134.1.25"},{"key":"2025121400210048000_11.12.e055864.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.02.058"},{"key":"2025121400210048000_11.12.e055864.18","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20679"},{"key":"2025121400210048000_11.12.e055864.19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2007-1007130","article-title":"Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension","volume":"19","author":"Garc\u00eda-Pag\u00e1n","year":"1999","journal-title":"Semin Liver Dis"},{"key":"2025121400210048000_11.12.e055864.20","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26754"},{"key":"2025121400210048000_11.12.e055864.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.07.017"},{"key":"2025121400210048000_11.12.e055864.22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.jvca.2016.12.002","article-title":"Relationship between intraoperative hypotension and acute kidney injury after living donor liver transplantation: a retrospective analysis","volume":"31","author":"Mizota","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025121400210048000_11.12.e055864.23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/lt.24166","article-title":"Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: a propensity score-matched analysis","volume":"21","author":"Hilmi","year":"2015","journal-title":"Liver Transpl"},{"key":"2025121400210048000_11.12.e055864.24","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.transproceed.2015.07.036","article-title":"Effects of continuous octreotide infusion on intraoperative transfusion requirements during orthotopic liver transplantation","volume":"47","author":"Byram","year":"2015","journal-title":"Transplant Proc"},{"key":"2025121400210048000_11.12.e055864.25","unstructured":"Troisi R , Croo A , Codarin E . Somatostatin (Eumedica\u00ae) Infusion Allows Modulating Graft Flows and Gradients in Liver Transplantation. Results of a Randomized, Double Blind, Placebo Controlled Trial [abstract]. In: American Transplant Congress; 2015. Am J Transplant 2015."},{"key":"2025121400210048000_11.12.e055864.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121400210048000_11.12.e055864.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c869"},{"key":"2025121400210048000_11.12.e055864.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03375.x"},{"key":"2025121400210048000_11.12.e055864.29","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025121400210048000_11.12.e055864.30","doi-asserted-by":"publisher","DOI":"10.1002\/pst.185"},{"key":"2025121400210048000_11.12.e055864.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.07.011"},{"key":"2025121400210048000_11.12.e055864.32","unstructured":"Martin D . Optimising the cardiovascular system following liver transplantation surgery. Study code ISRCTN10329248. Available: http:\/\/www.isrctn.com\/ISRCTN10329248"},{"key":"2025121400210048000_11.12.e055864.33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21563"},{"key":"2025121400210048000_11.12.e055864.34","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318225db4d"},{"key":"2025121400210048000_11.12.e055864.35","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/TP.0000000000001576","article-title":"Factors associated with short- and long-term liver graft survival in the United Kingdom: development of a UK donor liver index","volume":"101","author":"Collett","year":"2017","journal-title":"Transplantation"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-055864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:21:16Z","timestamp":1765700476000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-055864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-055864"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-055864","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}